Investors
This is where you will find financial information about Promore Pharma. You can download annual reports, quarterly reports and presentations and subscribe to our press releases and reports.
It is our ambition to provide the capital market, investors, shareholders and other stakeholders with relevant information to facilitate a fair valuation of the company and our external contacts. We strive to be as transparent as possible in all our actions. Do not hesitate to contact us if you require additional information.
Press releases
- Interim report January – September 2022
- Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2022
- Nomination Committee Appointed for the Annual General Meeting 2023 in Promore Pharma
- Promore Pharma provides an update on the Phase II clinical trial with ensereptide
- Promore Pharma Interim report January – June 2022
Interim report January – September 2022
Promore Pharma AB (publ) published its interim report for the third quarter 2022 on 29 November 2022.
The day after, the 30 November at 11:00 CET, the company will host a webcast telephone conference with President and CEO Jonas Ekblom, with an update for the quarter and upcoming activities. After the presentation there will be a Q&A session. The conference call will be held in Swedish.